Google
Trusted Resources: Education
Scientific literature and patient education texts
Recommendations for COVID Vaccination
source: Mayo Clinic
year: N/A
summary/abstract:We recommend that patients with myeloma and related disorders, whether on or off chemotherapy, receive COVID vaccination as soon as it is available and offered to them.
Note: Patients with myeloma and related disorders who have undergone stem cell transplantation can receive COVID vaccination starting around two months after stem cell transplantation.
myBinderRelated Content
-
AARDA National Briefing on COVID-19 and Autoimmune Disease: Research Insights, Treatment & Preventionhttps://www.youtube.com/watch?v=MYzOboYh...
-
COVID-19 Vaccine FAQ — Boston University School of Medicine Amyloidosis CenterIs the COVID-19 vaccine safe? How effec...
-
Specific Questions and Answers About COVID-19 for Transplant PatientsI Am a Transplant Patient. What Should I...
-
COVID-19 Vaccines Update: FDA and CDC Leaders Address the Rare Disease Communityhttps://www.youtube.com/watch?v=s9sLir7b...
-
COVID-19 Expert Answers Questions on Restrictions and MoreStay-at-home orders, how the virus that ...
-
NORD Launches Financial Assistance Program for Rare Disease Community Members Impacted by COVID-19At this time of crisis and with the heal...
-
How to Prepare Your Family in Case COVID-19 Spreads in Your Community – CDCHere is what you can do to prepare your ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Community Key Collaborator
Support for this landing page is provided by an independent education grant from
Translation of this platform made possible through an independent education grant from
Powered by
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
